| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/23/1992 | EP0504291A1 Novel proteins with oncostatin m activity and process for their preparation |
| 09/23/1992 | CA2106868A1 Compounds for use in the treatment of cancer |
| 09/22/1992 | WO1992016235A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | US5149804 Ecteinascidins 736 and 722 |
| 09/22/1992 | US5149801 Carboranes, anticarcinogenic agents, boron neutron capture therapy |
| 09/22/1992 | US5149781 Steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma |
| 09/22/1992 | US5149711 2-cyclopentenone derivatives |
| 09/22/1992 | CA2105378A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | CA2061662A1 Novel carboxylic amides |
| 09/22/1992 | CA1307753C Dna sequences, recombinant dna molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/20/1992 | WO1992016512A1 Anti-cancer compounds |
| 09/20/1992 | CA2106583A1 Anti-cancer compounds |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
| 09/17/1992 | WO1992015606A1 New inhibitors of endothelial cell proliferation |
| 09/17/1992 | WO1992015604A1 Anti-testosterone compounds and method of use thereof |
| 09/17/1992 | WO1992015599A1 OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS |
| 09/17/1992 | WO1992015583A1 Imidazoacridines and their antineoplastic use |
| 09/17/1992 | WO1992015582A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES |
| 09/17/1992 | WO1992015566A1 Nitrogen oxides of aza- and diaza-anthracenedione derivatives as antitumor agents |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015307A1 6,9-BIS(AMINO SUBSTITUTED)BENZO[g]PHTHALAZINE-5,10-DIONES AS ANTITUMOR AGENTS |
| 09/17/1992 | WO1992015300A1 6,9 BIS(SUBSTITUTED-AMINO)BENZO[g]ISOQUINOLINE-5,10-DIONES |
| 09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 09/17/1992 | CA2104582A1 6,9 bis(substituted-amino)benzo [g]isoquinoline-5,10-diones |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | EP0504017A1 Benzopyran derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/16/1992 | EP0503830A1 Trans-platinum compounds with anti-tumor activity, process for their preparation and compositions containing them |
| 09/16/1992 | EP0503829A2 Hirudin for the inhibition of cancer metastasis |
| 09/16/1992 | EP0503710A2 Flunarizine containing anti-neoplastic compositions |
| 09/16/1992 | EP0503548A1 Cyclic urea derivatives, medicaments contaning them and process for their preparation |
| 09/16/1992 | EP0503537A1 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones |
| 09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
| 09/16/1992 | EP0503301A2 Peptide derivatives and application thereof |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | CN1064407A Pharmaceutical composition |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/15/1992 | WO1991013989A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 09/15/1992 | US5147880 Estrogenic and antiestrogenic activity |
| 09/15/1992 | US5147878 Hypotensive, antiarrhythmia agents |
| 09/15/1992 | US5147860 Tan-1120, its derivatives, production and use thereof |
| 09/15/1992 | US5147854 Tgf-b compositions and method |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | CA2078010A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 09/15/1992 | CA1307523C Platium compounds suitable for use as pharmaceuticals |
| 09/15/1992 | CA1307466C Inhibition of protein kinase c by long-chain bases |
| 09/13/1992 | CA2062655A1 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/12/1992 | WO1992016612A2 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2105997A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/10/1992 | CA2061759A1 Trans-pt (iv) complexes |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502788A1 Trisubstituted triazines and pyrimidines, process for their preparation and pharmaceutical compositions containing them |
| 09/09/1992 | EP0502709A1 Gallium compounds |
| 09/09/1992 | EP0502668A1 Imidazoacridines and their antineoplastic use |
| 09/09/1992 | EP0502661A2 Heteroanthracycline anti-tumor analogues |
| 09/09/1992 | EP0502595A2 Amide chelates, their metal complexes and their use in diagnosis and therapy |
| 09/09/1992 | EP0502594A1 Chelates, their metal complexes as well as their use in diagnosis and therapy |
| 09/09/1992 | EP0502020A1 NOVEL BENZO [b] PHENANTHROLINE-1,7 DERIVATIVES, AND THEIR PREPARATION AND THERAPEUTICAL APPLICATIONS. |
| 09/09/1992 | CN1064278A 4-deoxy-4-epipodophyllotoxin derivatives or pharmaceutically acceptable salt thereof |
| 09/09/1992 | CN1064271A 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 09/09/1992 | CA2062407A1 Benzopirene derivatives, a process for the preparation thereof and the pharmaceutical compositions containing them |
| 09/09/1992 | CA2062388A1 Method and preparation for the inhibition or prevention of cancer metastasis |
| 09/09/1992 | CA2061891A1 Flunarizine containing anti-neoplastic compositions |
| 09/08/1992 | US5145872 Enzyme inhibitors, analgesics |
| 09/08/1992 | US5145863 Porphyrin compounds |
| 09/08/1992 | US5145848 Amino anthracenediones-bis platinum complexes, useful as antitumoral agents |
| 09/08/1992 | US5145847 Antiestrogens |
| 09/08/1992 | US5145839 Antitumor, AIDS |
| 09/08/1992 | CA2062483A1 Chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/08/1992 | CA2062454A1 Amide-chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/08/1992 | CA2062378A1 Trisubstituted triazimes and pyrimidines, process for their preparation and pharmaceutical compositions containing them |
| 09/08/1992 | CA1307288C Chemical compounds |
| 09/08/1992 | CA1307271C (1h-azo-1-ylmethyl)substituted benzotriazole derivatives |
| 09/08/1992 | CA1307256C Bbm-1675c and d antitumor antibiotics |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/07/1992 | CA2061653A1 Oral gallium complexes |
| 09/03/1992 | WO1992014707A1 Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them |
| 09/03/1992 | WO1992014471A1 Treatment of non-small cell lung carcinoma |
| 09/03/1992 | WO1992014469A1 Treatment of ovarian cancer |
| 09/03/1992 | WO1992014467A1 Therapeutic agents for the treatment of multidrug resistance to cancers |
| 09/03/1992 | DE4106570A1 Neue inhibitoren der endothelzell-proliferation New inhibitors of endothelial cell proliferation- |
| 09/02/1992 | EP0501250A1 Fucose-marked batracylin derivatives |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500928A1 Endocurietherapy |
| 09/02/1992 | EP0500751A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
| 09/02/1992 | EP0500739A1 Herbal treatment of malignancy. |
| 09/02/1992 | EP0500653A1 Inhibitors of purine nucleoside phosphorylase |
| 09/02/1992 | EP0437488A4 Animal model for human disease |
| 09/02/1992 | EP0401243B1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives |
| 09/02/1992 | CN1064018A Processes for preparation of compositions used in treatment of cell generation disorders |
| 09/01/1992 | US5144081 Sunscreen agents |
| 09/01/1992 | US5143907 Phosphite-borane compounds, and method of making and using the same |
| 09/01/1992 | US5143906 Kedarcidin antitumor chromophore and pharmaceutical composition containing same |
| 09/01/1992 | CA1306966C Human monocytes cultured in suspension in serum-free medium |
| 09/01/1992 | CA1306944C Lithium salt-containing pharmaceutical compositions |
| 08/29/1992 | WO1992015601A2 Heteroanthracycline antitumor analogs |
| 08/29/1992 | CA2104768A1 Heteroanthracycline antitumor analogs |
| 08/28/1992 | CA2061993A1 Fucose-bearing cytostatics |
| 08/27/1992 | WO1992014756A1 Therapeutically useful peptides and peptides fragments |
| 08/27/1992 | DE4105570A1 Verwendung eines bakterien- und eiweissfreien filtrats Use of a protein-free filtrate of bacteria and |